Viewing nowGabapentin Tablet 75 mg (Pregabalin)
Pregabalin 75mg
Tablet · Prescription medication
Samil Pharmaceutical Co., Ltd.

MFDS item code 201705790 · Approved 2017.07.20 · Insurance code 643903560
Treatment of peripheral and central neuropathic pain, adjunctive therapy for partial seizures, improvement of fibromyalgia
This medication is used to relieve peripheral and central neuropathic pain in adults. Additionally, it is effective as an adjunctive treatment for partial seizures in patients with epilepsy, whether or not accompanied by secondary generalized symptoms. Furthermore, it helps alleviate the symptoms of fibromyalgia. In summary, this medication is used for the treatment of neuropathic pain, partial seizures in epilepsy, and fibromyalgia.
This medication is administered orally, divided into two doses daily regardless of food. 1. Neuropathic Pain - Peripheral Neuropathic Pain: The starting dose is 150 mg daily, and may be increased to 300 mg daily within 3 to 7 days. If necessary, it can be increased up to a maximum of 600 mg daily at 7-day intervals. - Central Neuropathic Pain: The starting dose of 150 mg daily is administered.
The safety and efficacy data for children under 12 years of age and adolescents aged 12 to 17 years is insufficient; therefore, administration is not recommended.
This medication may increase the risk of suicidal thoughts and behaviors; therefore, any mood changes or depressive symptoms during treatment must be reported to healthcare professionals immediately. Patients with hypersensitivity to this medication should not take it. Diabetic patients should be cautious as weight gain may affect blood sugar control, and treatment should be stopped immediately if symptoms of angioedema occur. Elderly patients should take particular care at the beginning of treatment due to the risk of falls from dizziness or drowsiness. Temporary blurred vision or changes in vision may occur; if symptoms persist, consult a physician. Before administering this medication alone, adequate consultation is necessary regarding the discontinuation of any previously taken antiepileptic drugs. Abruptly stopping this medication may cause withdrawal symptoms such as insomnia, headache, nausea, and anxiety, so dosages should be tapered gradually according to the physician's instructions. Due to the risk of drug abuse, patients with a history of substance abuse should be extra cautious during use and report any abnormal behaviors immediately. Patients with impaired renal function may require dosage adjustments. Caution should be exercised when administering to patients with heart disease, particularly those with congestive heart failure. When taken with opioid analgesics, the risk of central nervous system depression is increased, so caution is advised. Patients with respiratory diseases, renal impairment, or the elderly may experience a risk of severe respiratory depression and should discuss their medication regimen with healthcare professionals. During early pregnancy, there is a risk of congenital malformations to the fetus, so this medication should only be administered when necessary, and women of childbearing age should use effective contraception. It can pass into breast milk, potentially affecting infants, so the decision to use this medication during breastfeeding should be made cautiously. Dizziness and drowsiness may occur when driving or operating machinery; therefore, care should be taken until the symptoms are confirmed. Severe skin reactions can occur rarely, so if any unusual symptoms like skin rash or swelling appear, discontinue use immediately and consult a physician. In case of overdose, symptoms may include confusion, drowsiness, and depression, and treatment such as blood dialysis may be necessary. Keep out of reach of children and avoid transferring to other containers, as this may lead to accidents.
Itching, severe swelling (edema), angioedema, chest tightness, difficulty breathing, cold sweat, pallor, severe rash accompanied by fever, blisters, skin peeling, pain in mucous membranes of the mouth/eyes, Stevens-Johnson syndrome, toxic epidermal necrolysis, shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities accompanied by cough and fever, yellowing of the skin or eyes (jaundice), extreme lethargy, sudden and severe
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent air and moisture from entering. The storage temperature should be between 1°C and 30°C at room temperature. By storing it this way, the effectiveness of the medication can be maintained for a longer period.
White or pale yellow round tablets
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowPregabalin 75mg
Tablet · Prescription medication
Samil Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 300mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Hanmi Pharm. Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Hanmi Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.